Thursday, May 28, 2009
Physicians Ask FDA Not to Rush into Opioid Risk Reduction Strategies
This article, by Emily P. Walker, Washing Correspondent for MedPage Today, discusses how doctors are asking the FDA to not rush into a Risk Evaluation and Mitigation (REMS), which would be intended to combat the misuse of opioid painkillers. The FDA is currently listening to input from physicians, patients, hospice workers, and pharmacists.
<< Back to Article Listings
If you wish to speak with a
Hospice Pharmacia Pharmacist or
Certified Technician, please call 877.882.7820.
Copyright ©, excelleRx Inc. 2010.
All Rights Reserved. No part of this work may be reproduced in any means
without the written permission of excelleRx Inc.
